Global Multiple Sclerosis Market to Surpass $33.57 Billion By 2032 Driven by Innovations in Disease-Modifying Therapies and Biomarker Research
The Multiple Sclerosis (MS) market is experiencing significant growth, fueled by a rising patient population, advancements in immunotherapies, and increasing awareness about early diagnosis. The …
